FrançaisQuest Diagnostics (DGX): financial analysis & fundamentals
📈 See the interactive version (live chart) →
Valuation & profitability
| Metric | Value | What it means |
|---|---|---|
| P/E (price / earnings) | 26.0 | The higher, the more growth the market expects. |
| Forward P/E | 20.3 | On next year's expected earnings. Lower than current P/E = rising earnings. |
| PEG (P/E ÷ growth) | 1.73 | Below 1 = cheap given growth; above 2 = expensive. |
| Net margin | 9% | Share of revenue that ends up as profit. |
| Revenue growth | 10% | Pace of revenue growth. |
| Price-to-book | 3.6 | Price relative to book value. |
| Market cap | $27.0 B | Total market value of the company. |
| Dividend yield | 1.51% | Annual dividend ~$3.26/share relative to price. |
Income statement (by year)
| Year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2022 | $9.9 B | $946 M | 10% |
| 2023 | $9.3 B | $854 M | 9% |
| 2024 | $9.9 B | $871 M | 9% |
| 2025 | $11.0 B | $992 M | 9% |
📊 Open the interactive Quest Diagnostics page (charts, live news) →
Frequently asked questions
Is Quest Diagnostics stock expensive?
Quest Diagnostics has a P/E of 26.0 (forward P/E 20.3) and a PEG of 1.73. A PEG below 1 is rather cheap given growth, above 2 is expensive. Verdict: reasonable valuation.
What is Quest Diagnostics's net margin?
Quest Diagnostics's net margin is about 9% — the share of revenue that ends up as net profit.
What is Quest Diagnostics's revenue?
Latest known revenue: $11.0 B for net income of $992 M. The year-by-year breakdown is in the income statement above.
What is Quest Diagnostics's market cap?
Quest Diagnostics (DGX) has a market cap of about $27.0 B.
Does Quest Diagnostics pay a dividend?
Yes: Quest Diagnostics pays about $3.26/share per year, i.e. roughly a 1.51% yield at the current price.
What is JPI Invest?
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
- 🏆 Analyst leaderboard by real reliability (beating their sector, not just riding the rally)
- 🎯 What to buy: 3 backtested methods over 6 years, from cautious to aggressive
- 💬 AI assistant: ask anything about any stock, with the numbers
- 📊 Portfolio tracking + 🔔 price alerts by email
⚠️ Educational information, not investment advice. Data: Yahoo Finance, recomputed by JPI Invest. A stock can be « cheap » for a bad reason.